{"slug":"ghk-cu-intro","verification":{"valid":true,"entries":38,"head":"a7965bcf7039dc288514d7dfcb8b7998b46762134835c8fd2008b29f73163c1c"},"energy":{"passes":38,"tokens_in":3183,"tokens_out":236,"tokens_total":3419,"cost_usd":0,"models":{"grok/grok-4.3":1,"grok-4.3":21,"system/audit-repair":11,"kimi/moonshot-v1-8k":1,"repair":1,"fill-slots":2,"owner":1},"head":"a7965bcf7039dc288514d7dfcb8b7998b46762134835c8fd2008b29f73163c1c"},"provenance":[{"ts":"2026-06-29T09:29:07.095Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: GHK-Cu: Collagen Scaffolding and Tissue Remodeling\n\nAudience: broad, aging/skin/tissue. The problem: GHK-Cu builds collagen scaffolding; production drops 60-80% with age. Why it matters: explains why older people heal with weaker tissue. Novelty: 7/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"ghk-cu-collagen-scaffolding-tissue-remodeling\",\n  \"title\": \"GHK-Cu: Collagen Scaffolding and Tissue Remodeling\",\n  \"body\": \"## GHK-Cu Production and Age-Related Decline\\n\\nPlasma GHK levels are approximately 200 ng/mL at age 20 and decline to 80 ng/mL by age 60 (mechanistic; human plasma measurement data).\\n\\nThis represents a roughly 60% reduction in circulating GHK (preclinical correlation with age).\\n\\n## Mechanisms of Collagen Scaffolding\\n\\nGHK-Cu increases synthesis of collagen, elastin, and glycosaminoglycans in fibroblast cultures (mechanistic; in vitro data).\\n\\nIt activates remodeling processes including chemoattraction of repair cells, increases in metalloproteinases and anti-proteases, and support for fibroblast proliferation (mechanistic).\\n\\nIn cell models, GHK-Cu combined with hyaluronic acid elevates collagen IV production up to 25.4-fold (preclinical; fibroblast and ex-vivo skin tests).\\n\\n## Evidence from Studies\\n\\n### In Vitro and Animal Data\\n\\nGHK-Cu stimulates collagen synthesis in fibroblast cultures, with effects observed at nanomolar concentrations (preclinical).\\n\\nRat wound models show increased collagen deposition when GHK-Cu is applied (preclinical).\\n\\n### Human Data\\n\\nControlled studies on aged skin demonstrated topical GHK-Cu tightens skin, improves elasticity and firmness, and reduces fine lines and wrinkles (human).\\n\\nA 12-week trial in women showed increased skin density, thickness, and elasticity with GHK-Cu cream (human).\\n\\nIn one comparison, GHK-Cu increased collagen deposition in 70% of participants after one month of topical use (human).\\n\\n## Tissue Remodeling Context\\n\\nGHK-Cu supports balanced extracellular matrix remodeling rather than suppression of repair pathways (mechanistic).\\n\\nNo human clinical trial data exist linking restored GHK-Cu levels to changes in healing outcomes in older adults (no human data).\\n\\nUser reports on topical or injectable use for skin appearance exist but are anecdotal and unv","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"fdb13fe84a6c3ecfe49655a67c713b84819f1e5c18d2a5a53b038d903bfa76d0"},{"ts":"2026-06-29T11:35:10.668Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fdb13fe84a6c3ecfe49655a67c713b84819f1e5c18d2a5a53b038d903bfa76d0","hash":"df4a7d21675c081436308b9c21be01caadabaf130fa462e57feacb6c4a6aef72"},{"ts":"2026-06-29T11:35:28.454Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"8 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"df4a7d21675c081436308b9c21be01caadabaf130fa462e57feacb6c4a6aef72","hash":"31f4db534e5d257d6d46b716d559e42ee9e1083a265f1dff9c8a583509426aa4"},{"ts":"2026-06-29T11:35:58.597Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"31f4db534e5d257d6d46b716d559e42ee9e1083a265f1dff9c8a583509426aa4","hash":"701b4b57665a8de659ce7aecdd36f7450c72e170de2bd46373971645c1f8a46b"},{"ts":"2026-06-29T11:36:17.900Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"701b4b57665a8de659ce7aecdd36f7450c72e170de2bd46373971645c1f8a46b","hash":"bc7b19478c670ce535ad412f0c88175aa9b3784107ddfc34bbfcc6ed0ca114b2"},{"ts":"2026-06-29T11:37:09.591Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"bc7b19478c670ce535ad412f0c88175aa9b3784107ddfc34bbfcc6ed0ca114b2","hash":"72b380dd217267b65783e7bd1343d2a96be2d45b72305bc69c04b653ea4f4622"},{"ts":"2026-06-29T11:37:28.532Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"72b380dd217267b65783e7bd1343d2a96be2d45b72305bc69c04b653ea4f4622","hash":"cb44070a0de84088b6151aec0e59128bec8dd18f5ef0a0a6591e2fc9ba6b212b"},{"ts":"2026-06-29T11:37:53.545Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cb44070a0de84088b6151aec0e59128bec8dd18f5ef0a0a6591e2fc9ba6b212b","hash":"0d4f9ce88e120fbfc775b60c2fafd42c5a110fed59d2dbc095410a10a3a3421c"},{"ts":"2026-06-29T11:38:17.803Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0d4f9ce88e120fbfc775b60c2fafd42c5a110fed59d2dbc095410a10a3a3421c","hash":"6391ffccc2493da319d5e1750eea3b80834ee4e76059bd4a56ec87e393de578b"},{"ts":"2026-06-29T11:39:12.248Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6391ffccc2493da319d5e1750eea3b80834ee4e76059bd4a56ec87e393de578b","hash":"852a9d9ec22c9c821224bc02fc5a2b782039252d614a52c927a6e4d861485ddf"},{"ts":"2026-06-29T11:39:31.913Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"852a9d9ec22c9c821224bc02fc5a2b782039252d614a52c927a6e4d861485ddf","hash":"ea7a7fcbe0c06dea0a9273bce7eebf2118e04835ddd49b76d0ef62b838567778"},{"ts":"2026-06-29T11:40:03.375Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ea7a7fcbe0c06dea0a9273bce7eebf2118e04835ddd49b76d0ef62b838567778","hash":"4bec4a822b6f50dd6c41daf5a95e610a4004b43e8ef08bb482a80f00f3b04538"},{"ts":"2026-06-29T12:49:29.055Z","model":"system/audit-repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4bec4a822b6f50dd6c41daf5a95e610a4004b43e8ef08bb482a80f00f3b04538","hash":"22217255cc8c484fb1a4e5ad65eea7d37606ab8efb59352d3bae1289a243880c"},{"ts":"2026-06-29T12:49:29.770Z","model":"system/audit-repair","action":"claim","prompt":"","input":"ghk-cu-intro c63","response":"GHK-Cu: Collagen Scaffolding and Tissue Remodeling is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"22217255cc8c484fb1a4e5ad65eea7d37606ab8efb59352d3bae1289a243880c","hash":"90299fafaf17266464f618df2580f45a48f5258f0481dfd31190e6d716331764"},{"ts":"2026-06-29T12:49:30.032Z","model":"system/audit-repair","action":"claim","prompt":"","input":"ghk-cu-intro c64","response":"Per this ledger on GHK-Cu: Collagen Scaffolding and Tissue Remodeling: 32 scientific and 28 anecdotal sources are catalogued; 25 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"90299fafaf17266464f618df2580f45a48f5258f0481dfd31190e6d716331764","hash":"868eba44eb9d9a9cc07e2c0c8586bf6036bca31ab41e561e852f3d22a7091fdb"},{"ts":"2026-06-29T12:49:30.326Z","model":"system/audit-repair","action":"claim","prompt":"","input":"ghk-cu-intro c65","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"868eba44eb9d9a9cc07e2c0c8586bf6036bca31ab41e561e852f3d22a7091fdb","hash":"75b9028a8318fa867cdee17d546d233d5b8cd23f416f327c4c2256cb83ab4c66"},{"ts":"2026-06-29T12:49:30.596Z","model":"system/audit-repair","action":"claim","prompt":"","input":"ghk-cu-intro c66","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"75b9028a8318fa867cdee17d546d233d5b8cd23f416f327c4c2256cb83ab4c66","hash":"c5b0c5a9912a8f8a57d2ecbb2d27776efb1bee189abc98164eb87a1a40a3ab36"},{"ts":"2026-06-29T12:49:30.687Z","model":"system/audit-repair","action":"claim","prompt":"","input":"ghk-cu-intro c67","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c5b0c5a9912a8f8a57d2ecbb2d27776efb1bee189abc98164eb87a1a40a3ab36","hash":"681597b3654424b555c98cf499fbaa18716846ea31c85f922fe69acd86246f18"},{"ts":"2026-06-29T12:49:31.607Z","model":"system/audit-repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"681597b3654424b555c98cf499fbaa18716846ea31c85f922fe69acd86246f18","hash":"265f5d5efb01dfbf748faccf63c003541924899d81282e5588b627161bf08695"},{"ts":"2026-06-29T13:22:58.890Z","model":"system/audit-repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"265f5d5efb01dfbf748faccf63c003541924899d81282e5588b627161bf08695","hash":"21f7d0ce6c52943de12f3dc00dc6817f4cd46c3f423f362d9157d19e1cc69295"},{"ts":"2026-06-29T13:23:00.208Z","model":"system/audit-repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"21f7d0ce6c52943de12f3dc00dc6817f4cd46c3f423f362d9157d19e1cc69295","hash":"ec1b205522184850558b5f437315acef5391267941d7ff3ff6d460f3e6931343"},{"ts":"2026-06-29T13:47:41.466Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"ghk-cu-intro","response":"I am adding explicit gaps regarding what is unknown and naming anecdotal sources to fulfill the instructions.","tokens_in":3183,"tokens_out":236,"cost":0,"prev":"ec1b205522184850558b5f437315acef5391267941d7ff3ff6d460f3e6931343","hash":"f75fe33dacd4f61a36383fdb04c1644eba89d30b18b27a2e64d796781ba89da7"},{"ts":"2026-06-29T13:53:51.305Z","model":"system/audit-repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f75fe33dacd4f61a36383fdb04c1644eba89d30b18b27a2e64d796781ba89da7","hash":"51c9f78ddea8a7e14e09dc40a6c5955793a6ad6d459a31d60700fa716b19b6ff"},{"ts":"2026-06-29T13:53:52.496Z","model":"system/audit-repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"51c9f78ddea8a7e14e09dc40a6c5955793a6ad6d459a31d60700fa716b19b6ff","hash":"4808c6bae458456417262a450dde765fbfb81e5428f5b7975b56d09ade719db6"},{"ts":"2026-06-29T16:44:31.413Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4808c6bae458456417262a450dde765fbfb81e5428f5b7975b56d09ade719db6","hash":"d042425eb9040001d49f75a3523d700f4841f6c501d8f017699e6854cb5026d3"},{"ts":"2026-06-29T16:44:51.841Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d042425eb9040001d49f75a3523d700f4841f6c501d8f017699e6854cb5026d3","hash":"2f36b0de49b53518285377a9ed4d75d9b14086a3358f1f488d238c718cafb94e"},{"ts":"2026-06-29T16:45:23.570Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2f36b0de49b53518285377a9ed4d75d9b14086a3358f1f488d238c718cafb94e","hash":"6d17e7405a692ed3360cd332dcdf9dfdbf49558da1b25aca0fcbacd54e9e0874"},{"ts":"2026-06-29T18:47:21.431Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6d17e7405a692ed3360cd332dcdf9dfdbf49558da1b25aca0fcbacd54e9e0874","hash":"1b9037f8045fc3f7e52cc4ac308296f308652f709305e625ccbfdde48efdce09"},{"ts":"2026-06-29T18:47:48.557Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1b9037f8045fc3f7e52cc4ac308296f308652f709305e625ccbfdde48efdce09","hash":"37583edd2ff44ae49670270e5ee0c883df5f28c3010355a6822b6f7f33a853a8"},{"ts":"2026-06-29T18:48:13.535Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"37583edd2ff44ae49670270e5ee0c883df5f28c3010355a6822b6f7f33a853a8","hash":"31afe48b589af2ec0743d14c94a58b27e4861c5df2d7e548bd90d6e5e5527261"},{"ts":"2026-06-29T18:48:55.994Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"31afe48b589af2ec0743d14c94a58b27e4861c5df2d7e548bd90d6e5e5527261","hash":"0474b6de0da780e64570f95c4c9320db07cb5c6f96063b9b165a9d24cb313283"},{"ts":"2026-06-29T18:49:27.907Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0474b6de0da780e64570f95c4c9320db07cb5c6f96063b9b165a9d24cb313283","hash":"740a07e0b9f1047a18d8b4acc0310aa818e7f072461cf33cc971f73f2a8a4d24"},{"ts":"2026-06-29T18:49:55.027Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"740a07e0b9f1047a18d8b4acc0310aa818e7f072461cf33cc971f73f2a8a4d24","hash":"ba22cda45bdfa4cabfd77cf195b10cd91aa3e5308e6b4134324dfff3315c7994"},{"ts":"2026-06-29T18:50:21.455Z","model":"grok-4.3","action":"sources","prompt":"","input":"ghk-cu-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ba22cda45bdfa4cabfd77cf195b10cd91aa3e5308e6b4134324dfff3315c7994","hash":"d74f33c8b845bd9a9df3b3dc84c94ca4cdb87a14d907c6cc07fc2929c861048a"},{"ts":"2026-06-29T20:12:02.132Z","model":"repair","action":"repair","prompt":"","input":"ghk-cu-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":1,\"cut_claims\":0,\"core\":0,\"cycle\":0,\"adjacent\":9}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d74f33c8b845bd9a9df3b3dc84c94ca4cdb87a14d907c6cc07fc2929c861048a","hash":"26df046ee6395161608452286f47e15a117acd48f941607e18acf8c76b2046f8"},{"ts":"2026-06-29T21:23:02.966Z","model":"fill-slots","action":"claim","prompt":"","input":"ghk-cu-intro c112","response":"GHK-Cu: Collagen Scaffolding and Tissue Remodeling is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"26df046ee6395161608452286f47e15a117acd48f941607e18acf8c76b2046f8","hash":"be70538d0deaa6382e3c0cf37034942c7a3bb4814dbae3c5dcf98c5364ad3018"},{"ts":"2026-06-29T21:23:05.386Z","model":"fill-slots","action":"claim","prompt":"","input":"ghk-cu-intro c113","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"be70538d0deaa6382e3c0cf37034942c7a3bb4814dbae3c5dcf98c5364ad3018","hash":"61430c34c045a5584f6d5c7628737c2d5e336caee38ad094ac06258e4b9ceee7"},{"ts":"2026-07-17T02:39:22.731Z","model":"owner","action":"voxel_divide","prompt":"","input":"ghk-cu-intro","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"61430c34c045a5584f6d5c7628737c2d5e336caee38ad094ac06258e4b9ceee7","hash":"a7965bcf7039dc288514d7dfcb8b7998b46762134835c8fd2008b29f73163c1c"}]}